Abstract
Hemolytic uremic syndrome (HUS) is a rare complication following solid organ transplantation. We report on a patient who underwent renal transplantation using Campath-1H induction and tacrolimus maintenance therapy who developed HUS, which was managed by plasma exchange and switch to Rapamycin. However, graft function could not be restored.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 386-389 |
| Number of pages | 4 |
| Journal | Transplant International |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2007 |
| Externally published | Yes |
Keywords
- Campath-1H
- Haemolytic uremic syndrome
- Rapamycin
- Renal transplantation
ASJC Scopus subject areas
- Transplantation
Fingerprint
Dive into the research topics of 'Hemolytic uremic syndrome following Campath-1H induction'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS